Latest Share Chat

REMOVE ADS

Synairgen Regulatory News (SNG)

Synairgen Information

There is currently no data for SNG

REMOVE ADS

Result of AGM

10 Nov 2011 12:40

RNS Number : 8789R

Synairgen plc

10 November 2011

Press Release

Synairgen plc

Result of AGM

Southampton, UK - 10 November 2011: The Board of Synairgen plc (LSE: SNG) announces that at the Annual General Meeting held today all resolutions proposed were duly passed by shareholders.

-Ends-

For further information, please contact:

Synairgen plc +44 (0) 23 8051 2800

Richard Marsden, Chief Executive Officer

John Ward, Finance Director

FinnCap

Geoff Nash, Christopher Raggett (Corporate Finance) +44 (0) 20 7220 0500

Stephen Norcross, Simon Starr (Corporate Broking)

Threadneedle Communications +44 (0) 20 7653 9850

Graham Herring

Josh Royston

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGBDBDBUXBBGBG

Date		Source	Headline
9th Apr 2025	7:00 am	RNS	Cancellation - Synairgen plc
3rd Apr 2025	7:00 am	RNS	Update on trading post cancellation
28th Mar 2025	2:21 pm	RNS	Result of General Meeting
11th Mar 2025	7:00 am	RNS	Proposed cancellation of trading on AIM
17th Jan 2025	12:55 pm	RNS	Holding(s) in Company
16th Jan 2025	3:42 pm	RNS	Martin Murphy appointed as Non-Executive Director
16th Jan 2025	3:42 pm	RNS	Result of General Meeting and Total Voting Rights
15th Jan 2025	5:37 pm	RNS	£18m raised to fund Phase 2 INVENT clinical trial
20th Dec 2024	7:00 am	RNS	Proposed Fundraising
30th Oct 2024	6:09 pm	RNS	Exercise of Share Options and Total Voting Rights
10th Oct 2024	5:05 pm	RNS	Results of AGM and Appointment of New Chairman
26th Sep 2024	7:00 am	RNS	Interim Results
18th Sep 2024	7:00 am	RNS	Appointment of New Chairman and Notice of AGM
5th Sep 2024	7:00 am	RNS	Board Change
27th Jun 2024	7:00 am	RNS	2023 Full Year Results
15th Nov 2023	7:00 am	RNS	Grant of Options
11th Oct 2023	7:00 am	RNS	Appointment of New Chief Financial Officer
3rd Oct 2023	7:00 am	RNS	Appointment of Chief Medical Officer
21st Sep 2023	7:00 am	RNS	Interim Results
29th Jun 2023	6:02 pm	RNS	Result of AGM
29th Jun 2023	10:00 am	RNS	Annual General Meeting Presentation
22nd Jun 2023	7:00 am	RNS	Grant of Options
23rd May 2023	7:00 am	RNS	Posting of Annual Report and Notice of AGM
27th Apr 2023	7:00 am	RNS	2022 Full Year Results
17th Apr 2023	7:00 am	RNS	Notice of Full Year results
13th Mar 2023	4:40 pm	RNS	Second Price Monitoring Extn
13th Mar 2023	4:35 pm	RNS	Price Monitoring Extension
3rd Feb 2023	4:40 pm	RNS	Second Price Monitoring Extn
3rd Feb 2023	4:35 pm	RNS	Price Monitoring Extension
17th Jan 2023	4:35 pm	RNS	Price Monitoring Extension
13th Jan 2023	4:40 pm	RNS	Second Price Monitoring Extn
13th Jan 2023	4:35 pm	RNS	Price Monitoring Extension
23rd Dec 2022	11:30 am	RNS	SPRINTER Trial Results Published
14th Dec 2022	4:35 pm	RNS	Price Monitoring Extension
1st Dec 2022	7:00 am	RNS	Board Changes
7th Nov 2022	4:40 pm	RNS	Second Price Monitoring Extn
7th Nov 2022	4:35 pm	RNS	Price Monitoring Extension
3rd Nov 2022	4:40 pm	RNS	Second Price Monitoring Extn
3rd Nov 2022	4:35 pm	RNS	Price Monitoring Extension
20th Oct 2022	4:35 pm	RNS	Price Monitoring Extension
6th Oct 2022	1:35 pm	RNS	Holding(s) in Company
4th Oct 2022	7:02 am	RNS	Data from the US NIH-led ACTIV-2 Phase 2 trial
29th Sep 2022	7:01 am	RNS	Board Changes
29th Sep 2022	7:00 am	RNS	Interim Results
20th Sep 2022	7:00 am	RNS	SPRINTER Long COVID data presented at IDWeek
15th Sep 2022	7:00 am	RNS	Notice of Interim Results
8th Sep 2022	4:40 pm	RNS	Second Price Monitoring Extn
8th Sep 2022	4:35 pm	RNS	Price Monitoring Extension
7th Sep 2022	7:00 am	RNS	Positive Findings from SG015 Tri-al Analysis
5th Sep 2022	7:00 am	RNS	Company Announce Collaboration on UNIVERSAL Trial

Latest Share Chat

Synairgen Regulatory News (SNG)

Result of AGM

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending